In this episode of Updates in Anesthesiology, Dr. Hadzic discusses the main findings from a 2025 BJA review by Tinsley et al. The study reported how to manage non-insulin diabetes medicines in the perioperative period safely. From metformin’s misunderstood safety profile to the hidden risks of SGLT-2 inhibitors and GLP-1 agonists, you’ll learn which drugs to hold, which to continue, and how to prevent complications like euglycaemic DKA and aspiration.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

Instagram- ⁠⁠instagram.com/nysora.inc/ ⁠⁠

LinkedIN- ⁠⁠linkedin.com/company/nysora-inc/⁠⁠

Facebook- ⁠⁠facebook.com/nysora⁠⁠

Twitter- ⁠⁠x.com/nysora⁠⁠

TikTok- ⁠⁠tiktok.com/@nysora_inc⁠⁠

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.